Other languages Hikma Pharmaceuticals PLC

Equities

Real-time Estimate Cboe Europe Other stock markets 09:48:45 2024-04-19 am EDT			5-day change	1st Jan Change
1,784 ^GBX	-0.31%		-1.44%	-0.67%

Apr. 15	Hikma Pharmaceuticals PLC Announces Executive Changes	CI
Mar. 11	FTSE 100 Closes Up 0.12% Ahead of U.K. Jobs Data	DJ

Hikma Pharmaceuticals PLC Announces Executive Changes	Apr. 15
New Zealand Shares Close Flat on Monday; Fletcher Building Chair Steps Down	Mar. 03
AFT Pharmaceuticals Limited Extends License for Maxigesic/Combogesic IV with Hikma Pharmaceuticals	Mar. 03
Barclays cuts Direct Line to equal weight	Feb. 29
Stocks called up following slew of FTSE 100 earnings	Feb. 29
Hyloris Pharmaceuticals: le Maxigesic IV commercialisé aux Etats-unis	Feb. 28
Hyloris Partner Hikma Launches Pain Medication in US, Obtains Approval in Canada	Feb. 28
Merck's Bridion faces generic threat from drugmaker Hikma	Feb. 26
Barclays raises Breedon but cuts Domino's Pizza	Feb. 23
HIKMA PHARMACEUTICALS : Strong Generics-led finish to 2023	Feb. 22
Berenberg raises Moneysupermarket.com to 'buy'	Feb. 22
Hikma boosts dividend after year of "significant progress"	Feb. 22
Drugmaker Hikma expects profit to be slightly lower in 2024	Feb. 22
Hikma Pharmaceuticals Reports Improved FY23 Profit, Revenue	Feb. 22
Hikma Pharmaceuticals PLC Provides Group Earnings Guidance for the Year 2024	Feb. 22
Hikma Pharmaceuticals PLC Announces Board Changes	Feb. 22
Hikma Pharmaceuticals PLC Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 22
FTSE 100 takes hit ahead of FOMC minutes	Feb. 21
New Zealand Shares Rebound on Friday Close; AFT Pharmaceuticals Raises Operation Profit Guidance	Feb. 15
AFT Pharmaceuticals Boosts Operating Profit Guidance for Fiscal Year 2024	Feb. 15

No results for this search

HIKMA PHARMACEUTICALS : Strong Generics-led finish to 2023

February 22, 2024 at 09:22 am EST